Penserra Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18
| Closed | -$2K | – | 1385 |
|
|
2023
Q3 | $2K | Buy |
18
+8
| +80% | +$889 | ﹤0.01% | 1208 |
|
|
2023
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 1250 |
|
|
2023
Q1 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 1091 |
|
|
2022
Q2 | – | Sell |
-16,707
| Closed | -$1.76M | – | 1564 |
|
|
2022
Q1 | $1.76M | Buy |
+16,707
| New | +$1.76M | 0.04% | 361 |
|
|
2020
Q4 | – | Sell |
-12,404
| Closed | -$963K | – | 1170 |
|
|
2020
Q3 | $963K | Buy |
+12,404
| New | +$963K | 0.04% | 271 |
|
|
2020
Q1 | – | Sell |
-4,554
| Closed | -$155K | – | 967 |
|
|
2019
Q4 | $155K | Buy |
+4,554
| New | +$155K | 0.01% | 504 |
|
|
2019
Q1 | – | Sell |
-536,151
| Closed | -$10.5M | – | 826 |
|
|
2018
Q4 | $10.5M | Buy |
+536,151
| New | +$10.5M | 1.02% | 28 |
|